[TXNDC17 protein overexpression in uterine papillary serous carcinoma is associated with clinicopathological characteristics and prognosis].

Peng, Q H; Yu, Y; Cheng, X D; Wang, X Y; Lyu, W G; Xie, X; Zhang, S F

Peng, Q H; Yu, Y; Cheng, X D; Wang, X Y; Lyu, W G; Xie, X; Zhang, S F.

Afiliação

Peng QH; Department of Gynecology and Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China.
Yu Y; Department of Gynecology and Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China.
Cheng XD; Women's Reproductive Health Key Laboratory of Zhejiang Province, Hangzhou 310006, China.
Wang XY; Women's Reproductive Health Key Laboratory of Zhejiang Province, Hangzhou 310006, China.
Lyu WG; Women's Reproductive Health Key Laboratory of Zhejiang Province, Hangzhou 310006, China.
Xie X; Women's Reproductive Health Key Laboratory of Zhejiang Province, Hangzhou 310006, China.
Zhang SF; Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Hangzhou 310006, China.

Zhonghua Yi Xue Za Zhi ; 102(32): 2506-2512, 2022 Aug 30.

Article em Zh | MEDLINE | ID: mdl-36008321

Assuntos

Carcinoma; Cistadenocarcinoma Seroso; Neoplasias Uterinas; Carcinoma/patologia; Cistadenocarcinoma Seroso/patologia; Feminino; Humanos; Estadiamento de Neoplasias; Prognóstico; Estudos Retrospectivos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Carcinoma / Cistadenocarcinoma Seroso Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: Zh Revista: Zhonghua Yi Xue Za Zhi Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google